BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
BIOR
Delisted
BIOR was delisted on the 10th of December, 2024.
42 hedge funds and large institutions have $8.72M invested in Biora Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
-2
Holders Change %
-4.55%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
10
Reduced
9
Closed
9
Calls
$226K
Puts
$60K
Net Calls
+$166K
Net Calls Change
-$305K
Top Buyers
| 1 |
ACM
Athyrium Capital Management
New York
|
$5.58M |
| 2 |
AC
Armistice Capital
New York
|
$1.1M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
$275K |
| 4 |
Millennium Management
New York
|
$244K |
| 5 |
Citadel Advisors
Miami,
Florida
|
$21.3K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
51
Virtu Financial
New York
| – | -$5K | -41 | Closed |
|
52
CIBC Private Wealth Group
Atlanta,
Georgia
| – | -$5K | -40 | Closed |
|